Laklai et al. showed that YAP signaling impaired TGF-β activation in association with pancreatic cancer progression in vivo, leading to the accumulation of a fibrotic matrix associated with aggressive tumors and poorer overall survival [51]. The gene discussed is TGFB1; the disease is pancreatic neoplasm.